|Articles|August 1, 2019
China Invests in Gene Therapy Research
Researchers in China are playing a role in advancing gene therapy development.
Advertisement
With a growing need for therapies to treat diseases in its growing population, researchers in China are playing a role in advancing gene therapy development. Eric Langer, managing partner, BioPlan Associates, highlights trends in this market in an interview with BioPharm International.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
How Engineered Exosomes Can Impact Targeted Therapies
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
